PharmacoEconomics

, Volume 22, Issue 3, pp 197–206 | Cite as

Psychometric Validation of the National Eye Institute Visual Function Questionnaire — 25 (NEI VFQ-25) French Version

In a Population of Patients Treated for Ocular Hypertension and Glaucoma
  • Jean-Phillipe Nordmann
  • Muriel Viala
  • Kate Sullivan
  • Benoît Arnould
  • Gilles Berdeaux
Original Research Article

Abstract

Objective: Physicians need reliable, valid and sensitive questionnaires to assess QOL related to glaucoma or ocular hypertension. This article presents the psychometric properties of the French version of the National Eye Institute Visual Function Questionnaire — 25 (NEI VFQ-25).

Methods: A mail survey was sent to 20 000 households. The survey identified 581 residents with glaucoma or ocular hypertension. Of these a random sample (n = 204) took part in a telephone survey during which the NEI VFQ-25 was completed by eligible patients (those taking at least one topical treatment for glaucoma or ocular hypertension on the day of the interview). Multi-trait analysis was performed to assess the construct validity of the questionnaire. Internal consistency reliability was assessed using Cronbach’s α and the average inter-item correlation. Known groups validity was assessed by comparing patients grouped by duration of glaucoma, adjusted for age and gender.

Results: One hundred and seventy-three patients participated in the survey. Analysis of convergent validity showed that all of the items in each scale correlated above 0.40 with their own scale except for the ‘driving’ scale. The success rate of the discriminant validity ranged from 57.1% to 100% except for the ‘driving’ scale, which was 7.1%. Cronbach’s α coefficients were all above 0.70 except the ‘driving’ score. Participants with glaucoma for less than 20 years consistently had better ‘global’, ‘near vision’, ‘distant vision’, ‘driving’, ’social function’ and ‘peripheral vision’ scores than those with disease of 20+ years duration, indicating better QOL in patients with a shorter disease duration.

Conclusion: The NEI VFQ-25 is a validated instrument to measure vision-targeted QOL in French populations with glaucoma.

Keywords

Glaucoma Internal Consistency Reliability Global Score Colour Vision Ocular Hypertension 

Notes

Acknowledgements

The work was supported by an unrestricted grant from Alcon France SA, Rueil-Malmaison, France, was conducted according to the local laws, and was contracted to Nelson Sofres Santé, Montrouge, France and to Mapi Values, Lyon, France. None of the authors had proprietary or commercial interests related to the manuscript.

References

  1. 1.
    Altangerel U, Spaeth GL, Rhee DJ. Visual function, disability, and psychological impact of glaucoma. Curr Opin Opthalmol 2003 Apr; 14 (2): 100–5CrossRefGoogle Scholar
  2. 2.
    Mangione CM, Lee PP, Pitts J, et al. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). Arch Ophthalmol 1998; 116: 1496–504PubMedGoogle Scholar
  3. 3.
    Mangione CM, Lee PP, Gutierrez PR, et al. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 2001; 119 (7): 1050–8PubMedGoogle Scholar
  4. 4.
    Rossi GC, Milano G, Tinelli C. The italian version of the 25-item national eye institute visual function questionnaire: translation, validity, and reliability. J Glaucoma 2003; 12 (3): 213–20PubMedCrossRefGoogle Scholar
  5. 5.
    Broman AT, Munoz B, West SK, et al. Psychometric properties of the 25-item NEI-VFQ in a hispanic population: proyecto VER. Invest Ophtalmol Vis Sci 2001; 42 (31): 606–13Google Scholar
  6. 6.
    Acquadro C, Jambon B, Ellis D, et al. Language and translations issues, In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia (PA): LippincottRaven, 1995: 63Google Scholar
  7. 7.
    Cronbach LJ. Coefficent alpha and the internal structure of tests. Psychometrika 1951; 16: 297–334CrossRefGoogle Scholar
  8. 8.
    Nunnally J. Psychometric theory. 2nd ed. New York: McGrawHill, 1978Google Scholar
  9. 9.
    Campbell DT, Fiske DW. Convergent and discriminant validation by the multitrait-multimethod matrix. Psychol Bull 1959; 56 (2): 81–105PubMedCrossRefGoogle Scholar
  10. 10.
    Hays R, Hayashi T. Beyond internal consistency reliability: rational and user’s guide for Multitrait Analysis Program on the microcomputer. Behav Res Methods 1990; 22 (2): 167–75CrossRefGoogle Scholar
  11. 11.
    Chassany O, Sagnier P, Marquis P, et al. Patient-reported outcomes: the example of health-related quality of life: a European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Inf J 2002; 36: 209–38CrossRefGoogle Scholar
  12. 12.
    Wolffsohn JS, Cochrane AL. Design of the low vision qualityof-life questionnaire (LVQOL) and measuring the outcome of low-vision rehabilitation. Am J Ophthalmol 2000; 130: 793–802PubMedCrossRefGoogle Scholar
  13. 13.
    Barber BL, Strahlman ER, Laibovitz R, et al. Validation of a questionnaire for comparing the tolerability of ophthalmic medications. Ophthalmology 1997 Feb; 104 (2): 334–42PubMedGoogle Scholar
  14. 14.
    Steinberg EP, Tielsch JM, Schein OD, et al. The VF-14. An index of functional impairment in patients with cataract. Arch Ophthalmol 1994 May; 112 (5): 630–8PubMedCrossRefGoogle Scholar
  15. 15.
    Vitale S, Schein OD, Meinert CL, et al. The refractive status and vision profile: a questionnaire to measure vision-related quality of life in persons with refractive error. Ophthalmology 2000; 107: 1529–39PubMedCrossRefGoogle Scholar
  16. 16.
    Mangione CM, Phillips RS, Seddon JM, et al. Development of the ’Activities of Daily Vision Scale’: a measure of visual functional status. Med Care 1992 Dec; 30 (12): 1111–26PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2004

Authors and Affiliations

  • Jean-Phillipe Nordmann
    • 1
  • Muriel Viala
    • 2
  • Kate Sullivan
    • 2
  • Benoît Arnould
    • 2
  • Gilles Berdeaux
    • 3
  1. 1.Centre Hospitalier des XV-XXParisFrance
  2. 2.MAPI ValuesLyonFrance
  3. 3.Alcon Research LtdRueil-MalmaisonFrance

Personalised recommendations